3/4/2014 8:12:37 AM
Ophthotech Corporation (Nasdaq:OPHT) today announced that the Company will host a live webcast in conjunction with its Research and Development (R&D) Day on Friday, March 7, 2014, beginning at 8:30 a.m. ET. A panel featuring leading retinal specialists will discuss the company’s expanded clinical programs for Fovista™ anti-PDGF therapy in combination with anti-VEGF drugs for wet AMD. In addition, an update on Zimura™, an inhibitor of complement factor C5 for the dry and wet forms of AMD, will also be provided.
Help employers find you! Check out all the jobs and post your resume.
comments powered by